Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Larson, RA; Druker, BJ; Guillot, F; O'Brien, SG; Riviere, GJ; Krahnke, T; Gathmann, I; Wang, Y; Study Group, IRIS; Collaborator Solenthaler, M (2008). Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood, 111(8), pp. 4022-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2007-10-116475

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Solenthaler, Max

ISSN:

0006-4971

Publisher:

American Society of Hematology

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:03

Last Modified:

04 May 2014 23:19

Publisher DOI:

10.1182/blood-2007-10-116475

Web of Science ID:

000255134700023

Additional Information:

-

URI:

https://boris.unibe.ch/id/eprint/27256 (FactScience: 105297)

Actions (login required)

Edit item Edit item
Provide Feedback